| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2d8d8b0590f2b5e245def776d8539331 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| filingDate |
2022-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce318220855df24dd100888f78425215
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57087b464b5ef75874969e4109822eaa |
| publicationDate |
2022-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022221786-A2 |
| titleOfInvention |
Compounds and pharmaceutical compositions that modulate brd4 |
| abstract |
Disclosed are compounds and salts thereof that are useful for modulating or degrading bromodomain (e.g., BRD4). |
| priorityDate |
2022-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |